Cargando…
Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600680/ http://dx.doi.org/10.1038/sj.bjc.6604800 |
| _version_ | 1782162194682609664 |
|---|---|
| author | Massard, C Voigt, J-J Laplanche, A Culine, S Lortholary, A Bugat, R Theodore, C Priou, F Kaminsky, M-C Lesimple, T Pivot, X Coudert, B Douillard, J-Y Merrouche, Y Fizazi, K |
| author_facet | Massard, C Voigt, J-J Laplanche, A Culine, S Lortholary, A Bugat, R Theodore, C Priou, F Kaminsky, M-C Lesimple, T Pivot, X Coudert, B Douillard, J-Y Merrouche, Y Fizazi, K |
| author_sort | Massard, C |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2600680 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2008 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-26006802009-12-03 Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? Massard, C Voigt, J-J Laplanche, A Culine, S Lortholary, A Bugat, R Theodore, C Priou, F Kaminsky, M-C Lesimple, T Pivot, X Coudert, B Douillard, J-Y Merrouche, Y Fizazi, K Br J Cancer Corrigendum Nature Publishing Group 2008-12-02 2008-11-25 /pmc/articles/PMC2600680/ http://dx.doi.org/10.1038/sj.bjc.6604800 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum Massard, C Voigt, J-J Laplanche, A Culine, S Lortholary, A Bugat, R Theodore, C Priou, F Kaminsky, M-C Lesimple, T Pivot, X Coudert, B Douillard, J-Y Merrouche, Y Fizazi, K Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title | Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title_full | Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title_fullStr | Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title_full_unstemmed | Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title_short | Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? |
| title_sort | carcinoma of an unknown primary: are egf receptor, her-2/neu, and c-kit tyrosine kinases potential targets for therapy? |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600680/ http://dx.doi.org/10.1038/sj.bjc.6604800 |
| work_keys_str_mv | AT massardc carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT voigtjj carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT laplanchea carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT culines carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT lortholarya carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT bugatr carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT theodorec carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT priouf carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT kaminskymc carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT lesimplet carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT pivotx carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT coudertb carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT douillardjy carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT merrouchey carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy AT fizazik carcinomaofanunknownprimaryareegfreceptorher2neuandckittyrosinekinasespotentialtargetsfortherapy |